ADAP Dividend History - Adaptimmune Therapeutics

Currently (March 2025) Adaptimmune Therapeutics Plc does not pay a dividend.

As of March 2025, Adaptimmune Therapeutics (ADAP) does not pay a dividend.

Top Dividend Payers in Biotechnology

Top Dividend Yield in Peer Group
Symbol Market Cap in USD Yield Yield on Cost
ADAP 115m 0.0% -
BION 2,400m 10.2% 10.6%
ORKA 888m 9.99% 10.2%
ABBV 373,460m 4.10% 13.2%
Top Dividend Grower in Peer Group
Symbol Market Cap in USD Grow Rating
ADAP 115m - 0.0%
SECARE 606m 10.4% 59.3%
BIM 14,588m 34.9% 56.7%
AMGN 168,527m 7.06% 69.0%

ADAP Dividend History

No dividends paid yet.

ADAP Dividend History - FAQ

Does ADAP pay dividends?

No, as of March 2025 ADAP does not pay a dividend.

What is the Dividend Yield of ADAP?

As of March 2025, ADAP`s dividend yield is 0.00%. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 0.45.

How often does ADAP pay dividends?

Over the last 12 months (TTM), ADAP has issued 0 dividend payments.

What is the next Ex-Dividend Date for ADAP?

The next ex-dividend date for Adaptimmune Therapeutics (ADAP) is unknown.

What is the Dividend Growth Rate of ADAP?

ADAP's average dividend growth rate over the past 5 years is -% per year.

What is the Yield on Cost of ADAP?

ADAP's 5-Year Yield on Cost is -%. This represents the effective dividend yield for an investor who bought Adaptimmune Therapeutics five years ago. It is calculated as the trailing 12-month dividend cash amount (-) divided by the purchase price five years ago (2.25):

What is the Payout Consistency of ADAP?

ADAP Payout Consistency is 0.0%.

Does ADAP have a good Dividend Yield?

ADAP`s 0.00% Dividend Yield is considered as unknown.

What is the Dividend Payout Ratio of ADAP?

The Dividend Payout Ratio of ADAP is unknown.

What is the Dividend Rating of ADAP?

ADAP`s Overall Dividend Rating is (unknown). Ratings surpassing 60 are regarded as favorable, exceeding 75 are strong, and surpassing 85 are exceptional.

Bonus Section: ADAP Outstanding Shares

What is the Trend of ADAP`s Outstanding Shares?

The Outstanding Shares of Adaptimmune Therapeutics are growing at a rate of 13.87% per year on average over the last 5 years. The Correlation Coefficent of the Outstanding Shares is 100.0%. Investors should be aware that the price of a stock often is negatively affected by an increasing number of shares.

Did Adaptimmune Therapeutics ever had a Stock Split?

No Stock Splits found.
Year Number of Shares Growth Rate
2015 54,000,000
2016 71,000,000 +31.48%
2017 88,000,000 +23.94%
2018 97,000,000 +10.23%
2019 105,000,000 +8.25%
2020 142,000,000 +35.24%
2021 156,000,000 +9.86%
2022 161,000,000 +3.21%
2023 201,000,000 +24.84%